A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants.

Détails

ID Serval
serval:BIB_C2A32D26E9BC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants.
Périodique
Blood
Auteur⸱e⸱s
Ligi I., Simoncini S., Tellier E., Vassallo P.F., Sabatier F., Guillet B., Lamy E., Sarlon G., Quemener C., Bikfalvi A., Marcelli M., Pascal A., Dizier B., Simeoni U., Dignat-George F., Anfosso F.
ISSN
1528-0020 (Electronic)
ISSN-L
0006-4971
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
118
Numéro
6
Pages
1699-1709
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
Low birth weight (LBW) is associated with increased risk of cardiovascular diseases at adulthood. Nevertheless, the impact of LBW on the endothelium is not clearly established. We investigate whether LBW alters the angiogenic properties of cord blood endothelial colony forming cells (LBW-ECFCs) in 25 preterm neonates compared with 25 term neonates (CT-ECFCs). We observed that LBW decreased the number of colonies formed by ECFCs and delayed the time of appearance of their clonal progeny. LBW dramatically reduced LBW-ECFC capacity to form sprouts and tubes, to migrate and to proliferate in vitro. The angiogenic defect of LBW-ECFCs was confirmed in vivo by their inability to form robust capillary networks in Matrigel plugs injected in nu/nu mice. Gene profile analysis of LBW-ECFCs demonstrated an increased expression of antiangiogenic genes. Among them, thrombospondin 1 (THBS1) was highly expressed at RNA and protein levels in LBW-ECFCs. Silencing THBS1 restored the angiogenic properties of LBW-ECFCs by increasing AKT phosphorylation. The imbalance toward an angiostatic state provide a mechanistic link between LBW and the impaired angiogenic properties of ECFCs and allows the identification of THBS1 as a novel player in LBW-ECFC defect, opening new perspectives for novel deprogramming agents.
Mots-clé
Animals, Blood Vessels/cytology, Blood Vessels/growth & development, Blotting, Western, Cell Proliferation, Cells, Cultured, Endothelial Cells/cytology, Endothelial Cells/metabolism, Female, Fetal Blood/cytology, Gene Expression Profiling, Humans, Infant, Low Birth Weight/blood, Infant, Newborn, Infant, Premature/blood, Male, Mice, Mice, Inbred Strains, Mice, Nude, Neovascularization, Physiologic/genetics, Phosphorylation, Proto-Oncogene Proteins c-akt/genetics, Proto-Oncogene Proteins c-akt/metabolism, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Stem Cell Transplantation/methods, Stem Cells/cytology, Stem Cells/metabolism, Thrombospondin 1/genetics, Thrombospondin 1/metabolism
Pubmed
Web of science
Open Access
Oui
Création de la notice
22/02/2015 11:03
Dernière modification de la notice
20/08/2019 16:37
Données d'usage